Resources

October 18, 2016 | Blog

With Health-Related Matters of the Heart on the Rise it is Even More Imperative to Stay Informed

With our newly revised Cardiovascular eModules your team will have what they really need to make a difference.

To guarantee our learners have the most recent and accurate information we recently partnered with two leading subject matter experts to revise our Cardiovascular eModules. These module updates allow learners to stay up to date with new guidelines, new drug therapies, and revised drug usages. The new modules are also presented with more visual enhancements to create a more efficient and user-friendly experience.  Some highlights of the major revisions are listed below:

  • A redesigned presentation of coronary artery disease (CAD) and acute coronary syndrome (ACS) to provide a more manageable learning experience. This content is now offered through two modules:
    • Coronary Artery Disease (CAD) and Acute Coronary Syndrome (ACS)—the Cause, Risk Factors, and Symptoms
    • Coronary Artery Disease (CAD) and Acute Coronary Syndrome (ACS)—Diagnosis, Treatment, and Prevention
  • Discussion of the new biologic lipid-modifying agents—PCSK9 inhibitors.
  • Updated ACC/AHA Blood Cholesterol Guidelines, and an explanation of the emphasis on individual risk status over target cholesterol goals.
  • Discussion of new drug classes approved for the treatment of heart failure, and inclusion of the 2016 Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure.
  • Content that reflects the 2014 Hypertension Guidelines from the Eighth Joint National Committee (JNC 8), including the JNC Recommendations for initial therapy and titration strategies.
  • A newly-designed module on antihypertensive drugs that emphasizes the JNC 8 Recommended Drug Classes.
  • More visual enhancements to help learners comprehend challenging concepts.

CMR partnered with these two leading subject matter experts on the Cardiovascular revision.

  • Gregory L. Freeman (MD, FACC) and is the Clinical Professor of Medicine in the Department of Medicine at the University of Texas, Health Science Center at San Antonio in San Antonio, TX
  • Robert L. Talbert (PharmD, FCCP, BCPS, FAHA) and is the Professor Emeritus of Pharmacy at the University of Texas at Austin, College of Pharmacy. He is also an Adjunct Professor of Medicine for Department of Medicine at the University of Texas, Health Science Center at San Antonio in
    San Antonio, TX.

Please see our catalog of resources to ensure your sales teams have the latest and greatest resources they need to maintain credible relationships and make a difference in their market.

 

Subscribe to Get More Great Posts